-
-
-
-
-
-
-
Zentalis Pharmaceuticals (ZNTL) Announces Intermittent Azenosertib Monotherapy Dosing Nearly Doubles Efficacy Over Continuous Dosing
-
-
-
-
-
-
-
Form 4 Distribution Solutions For: May 19 Filed by: HILLMAN LEE S
-
-
-
-
-
-
-
Reinsurance Group of America (RGA) Prices Senior Notes Offering
-
-
-
-
-
-
-
Form S-3ASR DOLLAR GENERAL CORP
-
-
-
-
-
-
-
Form S-3ASR BRUKER CORP
-
-
-
-
-
-
-
Autolus Therapeutics (AUTL) Presents Positive Results from Pivotal Phase 2 FELIX study
-
-
-
-
-
-
-
Form S-3/A Stereotaxis, Inc.
-
49,699 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All